Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Sharon Arrol"'
Autor:
Randall Morton, Christin Coomarasamy, Bruce Arroll, Sharon Arrol, Nadina Thwaites, William Brundell
Publikováno v:
Journal of Primary Health Care, Vol 15, Iss 1, Pp 67-70 (2023)
Introduction Counties Manukau Health Otolaryngology programme for general practitioners with special interest (GPwSI) was developed to provide a group of GPs with tools to manage low complexity, secondary otolaryngology (ORL) problems in their local
Externí odkaz:
https://doaj.org/article/fd32b44efd7f4a969d697ae8bb921727
Autor:
Adrian Trenholme, Rachel Webb, Shirley Lawrence, Sharon Arrol, Susan Taylor, Shanthi Ameratunga, Catherine A. Byrnes
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 2, Pp 641-643 (2021)
In March 2020, a national elimination strategy for coronavirus disease was introduced in New Zealand. Since then, hospitalizations for lower respiratory tract infection among infants
Externí odkaz:
https://doaj.org/article/8ba8bd6b913c442880e588ad6a425dd0
Autor:
William Brundell, Nadina Thwaites, Sharon Arrol, Bruce Arroll, Christin Coomarasamy, Randall Morton
Publikováno v:
Journal of Primary Health Care. 15:67-70
Introduction Counties Manukau Health Otolaryngology programme for general practitioners with special interest (GPwSI) was developed to provide a group of GPs with tools to manage low complexity, secondary otolaryngology (ORL) problems in their local
Publikováno v:
Pacific Health Dialog. 21:587-595
Background: Despite numerous published prospective studies, evidence to support use of prophylactic incisional negative pressure wound therapy, for obstetric and gynaecologic surgery, is conflicting. Aim: To evaluate if wound-related presentations to
Autor:
Sharon Arrol, Shanthi Ameratunga, Rachel Webb, Catherine A. Byrnes, Susan S. Taylor, Adrian Trenholme, Shirley Lawrence
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 2, Pp 641-643 (2021)
Emerging Infectious Diseases
Emerging Infectious Diseases
In March 2020, a national elimination strategy for coronavirus disease was introduced in New Zealand. Since then, hospitalizations for lower respiratory tract infection among infants
Autor:
Kam Fai Tse, Vincent A. Pollack, Michael Jeffers, Haihong Zhong, William J. LaRochelle, John Macdougall, Sharon Arrol, William F. Hahne, Suresh Shenoy, Henri Lichenstein, Michael Torgov, Sam Xie, Robert W. Gerwien, Peter D. Senter, Enrique Alvarez
Publikováno v:
Cancer Chemotherapy and Pharmacology. 60:423-435
To investigate the pharmacological properties of the CR011-vcMMAE fully human antibody-drug conjugate (ADC), such as dose titrations, quantitation of the time (days) to complete regression, pharmacokinetics, and schedule dependency. Our prior study c
Publikováno v:
Atherosclerosis. 150:255-264
We have investigated the effect of fatty acids on the rate of apolipoprotein B (apo B) secretion by human hepatoma cells (Hep G2). When Hep G2 cells were maintained in tissue culture flasks oleic acid up to 0.4 mM increased apo B secretion in a dose-
Autor:
Sharon Arrol, Michael I. Mackness, Aamir Ayub, Bharti Mackness, Jeetesh V. Patel, Paul N. Durrington
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 19:330-335
Abstract —HDL has been shown to prevent the oxidative modification of LDL. The antioxidant activity of HDL is believed to reside in its enzymes, particularly paraoxonase. Human serum paraoxonase (PON1) is closely associated with a specific HDL subf
Autor:
John E Miller, Wajdi Turkie, Bashir Abuasha, Kay Julier, Sharon Arrol, Michael I. Mackness, Bharti Mackness, Paul N. Durrington, Andrew J.M. Boulton
Publikováno v:
Atherosclerosis. 139:341-349
Human serum paraoxonase (PON1) is located on high density lipoprotein and has been implicated in the detoxification of organophosphates and possibly in the prevention of low density lipoprotein lipid peroxidation. PON1 has two genetic polymorphisms b